{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:19:04Z","timestamp":1775870344223,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007765","name":"Shenyang Science and Technology Bureau","doi-asserted-by":"publisher","award":["18-014-4-20"],"award-info":[{"award-number":["18-014-4-20"]}],"id":[{"id":"10.13039\/501100007765","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.biopha.2019.109530","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T05:08:53Z","timestamp":1570684133000},"page":"109530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Investigation of candidate molecular biomarkers for expression profile analysis of the Gene expression omnibus (GEO) in acute lymphocytic leukemia (ALL)"],"prefix":"10.1016","volume":"120","author":[{"given":"Guojun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongtao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huinan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuogang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biopha.2019.109530_bib0005","first-page":"731","article-title":"Leukemia: an overview for primary care","volume":"89","author":"Davis","year":"2014","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.biopha.2019.109530_bib0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/B978-0-12-380916-2.00006-1","article-title":"Genetic alterations targeting lymphoid development in acute lymphoblastic leukemia","volume":"94","author":"Collins-Underwood","year":"2011","journal-title":"Curr. Top. Dev. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109530_bib0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.biopha.2019.109530_bib0020","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.mayocp.2016.09.010","article-title":"Adult acute lymphoblastic leukemia","volume":"91","author":"Paul","year":"2016","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.biopha.2019.109530_bib0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3324\/haematol.2008.004150","article-title":"T-cell acute lymphoblastic leukemia","volume":"94","author":"Chiaretti","year":"2009","journal-title":"HAEMATOLOGICA"},{"issue":"2","key":"10.1016\/j.biopha.2019.109530_bib0030","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/leu.2015.230","article-title":"Improved survival in adult patients with acute lymphoblastic leukemia in the Netherlands: a population-based study on treatment, trial participation and survival","volume":"30","author":"Dinmohamed","year":"2016","journal-title":"LEUKEMIA"},{"issue":"2","key":"10.1016\/j.biopha.2019.109530_bib0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/leu.2015.230","article-title":"Improved survival in adult patients with acute lymphoblastic leukemia in the Netherlands: a population-based study on treatment, trial participation and survival","volume":"30","author":"Dinmohamed","year":"2016","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.biopha.2019.109530_bib0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/leu.2009.261","article-title":"Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children\u2019s oncology group","volume":"24","author":"Salzer","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2019.109530_bib0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","article-title":"The gene expression omnibus database","volume":"1418","author":"Clough","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2019.109530_bib0050","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets--update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.biopha.2019.109530_bib0055","first-page":"285","article-title":"Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer","volume":"7","author":"Niwa","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2019.109530_bib0060","doi-asserted-by":"crossref","DOI":"10.4161\/onci.23660","article-title":"The CCL5\/CCR5 axis promotes metastasis in basal breast cancer","volume":"2","author":"Velasco-Velazquez","year":"2013","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.biopha.2019.109530_bib0065","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0888-7543(90)90485-D","article-title":"Localization of a human T-cell-specific gene, RANTES (D17S136E), to chromosome 17q11.2-q12","volume":"6","author":"Donlon","year":"1990","journal-title":"Genomics"},{"issue":"6","key":"10.1016\/j.biopha.2019.109530_bib0070","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/annonc\/mdl053","article-title":"Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer","volume":"17","author":"Andre","year":"2006","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2019.109530_bib0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canlet.2008.03.018","article-title":"The inflammatory chemokines CCL2 and CCL5 in breast cancer","volume":"267","author":"Soria","year":"2008","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.biopha.2019.109530_bib0080","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1172\/JCI41732","article-title":"Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice","volume":"120","author":"Berres","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.biopha.2019.109530_bib0085","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1084\/jem.179.5.1689","article-title":"Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells","volume":"179","author":"Devergne","year":"1994","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.biopha.2019.109530_bib0090","doi-asserted-by":"crossref","first-page":"G949","DOI":"10.1152\/ajpgi.00215.2003","article-title":"Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration","volume":"285","author":"Schwabe","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"5231","key":"10.1016\/j.biopha.2019.109530_bib0095","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1126\/science.7569902","article-title":"Activation of dual T cell signaling pathways by the chemokine RANTES","volume":"269","author":"Bacon","year":"1995","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.biopha.2019.109530_bib0100","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1349-7006.2005.00059.x","article-title":"Chemokines in tumor progression and metastasis","volume":"96","author":"Tanaka","year":"2005","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.biopha.2019.109530_bib0105","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bcp.2008.11.014","article-title":"CCL5 increases lung cancer migration via PI3K, Akt and NF-kappaB pathways","volume":"77","author":"Huang","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109530_bib0110","first-page":"8","article-title":"CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors","author":"Walens","year":"2019","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.biopha.2019.109530_bib0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-018-0787-z","article-title":"CCL2\/CCL5 secreted by the stroma induce IL-6\/PYK2 dependent chemoresistance in ovarian cancer","volume":"17","author":"Pasquier","year":"2018","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2019.109530_bib0120","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/cas.13494","article-title":"C-C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment","volume":"109","author":"Urata","year":"2018","journal-title":"Cancer Sci."},{"issue":"21","key":"10.1016\/j.biopha.2019.109530_bib0125","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1038\/onc.2016.458","article-title":"Cancer-FOXP3 directly activated CCL5 to recruit FOXP3(+)Treg cells in pancreatic ductal adenocarcinoma","volume":"36","author":"Wang","year":"2017","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.biopha.2019.109530_bib0130","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ceb.2004.07.009","article-title":"Roles of fascin in cell adhesion and motility","volume":"16","author":"Adams","year":"2004","journal-title":"Curr. Opin. Cell Biol."},{"issue":"11","key":"10.1016\/j.biopha.2019.109530_bib0135","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1091\/mbc.8.11.2345","article-title":"Characterization of cell-matrix adhesion requirements for the formation of fascin microspikes","volume":"8","author":"Adams","year":"1997","journal-title":"Mol. Biol. Cell"},{"issue":"34","key":"10.1016\/j.biopha.2019.109530_bib0140","doi-asserted-by":"crossref","first-page":"11036","DOI":"10.1021\/bi960789j","article-title":"Binding of hisactophilin I and II to lipid membranes is controlled by a pH-dependent myristoyl-histidine switch","volume":"35","author":"Hanakam","year":"1996","journal-title":"Biochemistryus"},{"issue":"Pt 17","key":"10.1016\/j.biopha.2019.109530_bib0145","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1242\/jcs.022509","article-title":"Rac regulates the interaction of fascin with protein kinase C in cell migration","volume":"121","author":"Parsons","year":"2008","journal-title":"J. Cell. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2019.109530_bib0150","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1369\/jhc.7A7353.2007","article-title":"Fascin expression in human embryonic, fetal, and normal adult tissue","volume":"56","author":"Zhang","year":"2008","journal-title":"J. Histochem. Cytochem."},{"issue":"3","key":"10.1016\/j.biopha.2019.109530_bib0155","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/path.2894","article-title":"The roles of fascins in health and disease","volume":"224","author":"Hashimoto","year":"2011","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2019.109530_bib0160","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1158\/1078-0432.186.11.1","article-title":"The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course","volume":"11","author":"Yoder","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2019.109530_bib0165","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1158\/1078-0432.CCR-08-1789","article-title":"Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer","volume":"15","author":"Darnel","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2019.109530_bib0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1746-1596-5-41","article-title":"Effects of small interfering RNAs targeting fascin on human esophageal squamous cell carcinoma cell lines","volume":"5","author":"Ortiz","year":"2010","journal-title":"Diagn. Pathol."},{"issue":"5","key":"10.1016\/j.biopha.2019.109530_bib0175","doi-asserted-by":"crossref","first-page":"742","DOI":"10.5858\/2007-131-742-FEIDLB","article-title":"Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma","volume":"131","author":"Bakshi","year":"2007","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"52","key":"10.1016\/j.biopha.2019.109530_bib0180","article-title":"Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis","volume":"11","author":"Tan","year":"2013","journal-title":"BMC Med."},{"issue":"5","key":"10.1016\/j.biopha.2019.109530_bib0185","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.bbagen.2019.02.009","article-title":"Heparan sulfate in chronic kidney diseases: exploring the role of 3-O-sulfation","volume":"1863","author":"Ferreras","year":"2019","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.biopha.2019.109530_bib0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.matbio.2014.01.001","article-title":"A personal voyage through the proteoglycan field","volume":"35","author":"Lindahl","year":"2014","journal-title":"Matrix Biol."},{"issue":"3","key":"10.1016\/j.biopha.2019.109530_bib0195","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1042\/bj2470687","article-title":"Characterization and N-terminal sequence of a heparan sulphate proteoglycan synthesized by endothelial cells in culture","volume":"247","author":"Castillo","year":"1987","journal-title":"Biochem. J."},{"issue":"Pt 17","key":"10.1016\/j.biopha.2019.109530_bib0200","first-page":"3799","article-title":"Syndecan-4 signaling at a glance","volume":"126","author":"Elfenbein","year":"2013","journal-title":"J. Cell. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2019.109530_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101931","article-title":"Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma","volume":"9","author":"Chu","year":"2014","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.biopha.2019.109530_bib0210","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1038\/onc.2016.482","article-title":"Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality","volume":"36","author":"Tse","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2019.109530_bib0215","first-page":"470","article-title":"Heparan sulfate: a ubiquitous glycosaminoglycan with multiple roles in immunity","volume":"4","author":"Simon","year":"2013","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2019.109530_bib0220","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1111\/febs.12180","article-title":"Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma","volume":"280","author":"Reijmers","year":"2013","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.biopha.2019.109530_bib0225","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1189\/jlb.1A0913-502R","article-title":"Chondroitin sulfate activates B cells in vitro, expands CD138+ cells in vivo, and interferes with established humoral immune responses","volume":"96","author":"Bruhl","year":"2014","journal-title":"J. Leukoc. Biol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219326289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219326289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:49:57Z","timestamp":1760096997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219326289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":45,"alternative-id":["S0753332219326289"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109530","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of candidate molecular biomarkers for expression profile analysis of the Gene expression omnibus (GEO) in acute lymphocytic leukemia (ALL)","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109530"}}